⌘K

Login Start Free

Home/Filings/4/0000950170-24-128956

4//SEC Filing

Gall Matthew 4

Accession 0000950170-24-128956

CIK 0001808865other

View on SEC.gov Company Profile

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 7:59 PM ET

Size

4.5 KB

Accession

0000950170-24-128956

Insider Transaction Report

Form 4

Period: 2024-11-19

iTeos Therapeutics, Inc.ITOS

Chief Financial Officer

Transactions

Purchase
Common Stock
2024-11-19$7.73/sh+5,000$38,635→ 65,429 total

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1

filerCIK 0001816194

Filing Metadata

Form type: 4
Filed: Nov 18, 7:00 PM ET
Accepted: Nov 19, 7:59 PM ET
Size: 4.5 KB

View on SEC.gov